Seattle Genetics | SGEN - Mitarbeiter Gesamtzahl



Mitarbeiter Veränderung Datum
AbbVie 55K 5K 2024-12
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Amgen 28K 1.3K 2024-12
Astellas Pharma 13.64K 1.11K 2025-12
Bayer 99.72K 1.65K 2023-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Celldex Therapeutics 186 26 2024-12
Daiichi Sankyo 19.76K 1.04K 2025-12
Eisai 13.51K 2.44K 2025-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
Exelixis 1.15K 163 2025-12
Genmab 2.68K 478 2024-12
Gilead Sciences 17.6K 400 2024-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Glaxosmithkline GBP 69.4K 20.7K 2022-12
Incyte 2.62K 93 2024-12
Insmed 1.27K 359 2024-12
Karyopharm Therapeutics 325 60 2023-12
MacroGenics 339 18 2023-12
Merck 75K 3K 2024-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Puma Biotechnology 185 7 2023-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Sanofi 84.59K 3.41K 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Takeda 47.46K 1.83K 2025-12
Vertex Pharmaceuticals 6.1K 700 2024-12
Xencor 250 30 2024-12